Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Bard

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Journal of Molecular Medicine (Berlin, Germany)|December 18, 2025
Preclinical evaluation of [<sup>11</sup>C]CHDI-009R for quantification of mutant huntingtin aggregatesFranziska Zajicek, Liesbeth Everix, Annemie Van Eetveldt, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2007
Thiophene substituted acylguanidines as BACE1 inhibitorsWilliam F Fobare, William R Solvibile, Albert J Robichaud, et al.
Journal of Medicinal Chemistry|September 18, 2009
Aminoimidazoles as potent and selective human beta-secretase (BACE1) inhibitorsMichael S Malamas, Jim Erdei, Iwan Gunawan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 19, 2016
Longitudinal Small-Animal PET Imaging of the zQ175 Mouse Model of Huntington Disease Shows In Vivo Changes of Molecular Targets in the Striatum and Cerebral CortexJenny Häggkvist, Miklós Tóth, Lenke Tari, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 24, 2022
Biodistribution and dosimetry in human healthy volunteers of the PET radioligands [<sup>11</sup>C]CHDI-00485180-R and [<sup>11</sup>C]CHDI-00485626, designed for quantification of cerebral aggregated mutant huntingtinAline Delva, Michel Koole, Kim Serdons, et al.
Journal of Medicinal Chemistry|December 9, 2009
Design and synthesis of 5,5'-disubstituted aminohydantoins as potent and selective human beta-secretase (BACE1) inhibitorsMichael S Malamas, Jim Erdei, Iwan Gunawan, et al.
Aging Cell|August 24, 2024
Age-related increase of CD38 directs osteoclastogenic potential of monocytic myeloid-derived suppressor cells through mitochondrial dysfunction in male miceRamkumar Thiyagarajan, Lixia Zhang, Omar D Glover, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 17, 2025
PET imaging with [¹¹C]CHDI-00485180-R, designed as radioligand for aggregated mutant huntingtin, in people with Huntington's diseaseAline Delva, Michel Koole, Kim Serdons, et al.
Bioorganic & Medicinal Chemistry|January 5, 2010
Di-substituted pyridinyl aminohydantoins as potent and highly selective human beta-secretase (BACE1) inhibitorsMichael S Malamas, Keith Barnes, Matthew Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|August 13, 2011
New pyrazolyl and thienyl aminohydantoins as potent BACE1 inhibitors: exploring the S2' regionMichael S Malamas, Jim Erdei, Iwan Gunawan, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Journal of Molecular Medicine (Berlin, Germany)|December 18, 2025
Preclinical evaluation of [<sup>11</sup>C]CHDI-009R for quantification of mutant huntingtin aggregatesFranziska Zajicek, Liesbeth Everix, Annemie Van Eetveldt, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2007
Thiophene substituted acylguanidines as BACE1 inhibitorsWilliam F Fobare, William R Solvibile, Albert J Robichaud, et al.
Journal of Medicinal Chemistry|September 18, 2009
Aminoimidazoles as potent and selective human beta-secretase (BACE1) inhibitorsMichael S Malamas, Jim Erdei, Iwan Gunawan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 19, 2016
Longitudinal Small-Animal PET Imaging of the zQ175 Mouse Model of Huntington Disease Shows In Vivo Changes of Molecular Targets in the Striatum and Cerebral CortexJenny Häggkvist, Miklós Tóth, Lenke Tari, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 24, 2022
Biodistribution and dosimetry in human healthy volunteers of the PET radioligands [<sup>11</sup>C]CHDI-00485180-R and [<sup>11</sup>C]CHDI-00485626, designed for quantification of cerebral aggregated mutant huntingtinAline Delva, Michel Koole, Kim Serdons, et al.
Journal of Medicinal Chemistry|December 9, 2009
Design and synthesis of 5,5'-disubstituted aminohydantoins as potent and selective human beta-secretase (BACE1) inhibitorsMichael S Malamas, Jim Erdei, Iwan Gunawan, et al.
Aging Cell|August 24, 2024
Age-related increase of CD38 directs osteoclastogenic potential of monocytic myeloid-derived suppressor cells through mitochondrial dysfunction in male miceRamkumar Thiyagarajan, Lixia Zhang, Omar D Glover, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 17, 2025
PET imaging with [¹¹C]CHDI-00485180-R, designed as radioligand for aggregated mutant huntingtin, in people with Huntington's diseaseAline Delva, Michel Koole, Kim Serdons, et al.
Bioorganic & Medicinal Chemistry|January 5, 2010
Di-substituted pyridinyl aminohydantoins as potent and highly selective human beta-secretase (BACE1) inhibitorsMichael S Malamas, Keith Barnes, Matthew Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|August 13, 2011
New pyrazolyl and thienyl aminohydantoins as potent BACE1 inhibitors: exploring the S2' regionMichael S Malamas, Jim Erdei, Iwan Gunawan, et al.
Pageof 8